Results 91 to 100 of about 13,398 (133)
Some of the next articles are maybe not open access.

Egg Hypersensitivity and Measles-Mumps-Rubella Vaccine Administration

Pediatrics, 1991
Because reports have described egg-sensitive individuals in whom anaphylaxis developed after measles vaccination, current recommendations include delaying administration of egg-derived vaccines until skin testing can be performed. Specifically, the 1988 Red Book recommends skin testing via scratch, prick, or puncture with 1:10 dilution of the vaccine ...
S A, Beck   +3 more
openaire   +2 more sources

Depressed Lymphocyte Function after Measles-Mumps-Rubella Vaccination

Journal of Infectious Diseases, 1975
Healthy children receiving routine measles-mumps-rubella vaccine developed an impaired in vitro lymphocyte response to stimulation with antigen (Candida) but not with mitogen (phytohemagglutinin and pokeweed mitogen). Response of lymphocytes was determined by measurement of the amount of [14C]thymidine incorporated by the cells.
T P, Munyer   +3 more
openaire   +2 more sources

Aseptic meningitis after measles–mumps–rubella (MMR) vaccination

British Journal of Biomedical Science, 2016
There are several most commonly used mumps vaccine strains. The Jeryl Lynn strain was licensed in the USA in 1967, and by 1992 it had been administered to approximately 135 million children and adu...
Setareh, Mamishi   +5 more
openaire   +2 more sources

Combined Vaccine Against Measles, Mumps, Rubella, and Varicella

Pediatrics, 1988
A combined measles, mumps, rubella, and varicella vaccine produced seroconversions for all four components similar to that found if measles, mumps, and rubella vaccine or live varicella vaccine were given separately. In addition, those exposed to varicella were completely protected or had only a mild rash.
P A, Brunell   +3 more
openaire   +2 more sources

Trivalent Combined Measles-Mumps-Rubella Vaccine

JAMA, 1971
Four lots of combined trivalent Moraten measles, Jeryl Lynn mumps, and HPV-77 duck rubella vaccine were administered to a total of 715 children, 7 months to 7 years of age, who were initially without antibody against any of the three viruses. Overall, 96% of the children developed measles hemagglutination-inhibiting, 95% developed mumps neutralizing ...
openaire   +1 more source

Designing spatial and temporal control of vaccine responses

Nature Reviews Materials, 2021
Shih Hao Ou, Wei Luo, Bali Pulendran
exaly  

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Nature Reviews Clinical Oncology, 2021
Aakash Desai   +2 more
exaly  

Combination measles, mumps, rubella and varicella vaccine.

Pediatrics, 1986
A comparative clinical trial was conducted in 15- to 17-month-old healthy children to compare an investigational combination measles, mumps, rubella, varicella (MMRV) vaccine v standard measles, mumps, rubella vaccine followed 6 weeks later with the varicella (MMR + V) vaccine.
A M, Arbeter   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy